[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2023_607-erwgr-11-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":32,"citing_decisions":43,"is_thin":44},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2023_607","zur Änderung der Verordnungen (EU) 2017\u002F745 und (EU) 2017\u002F746 hinsichtlich der Übergangsbestimmungen für bestimmte Medizinprodukte und In-vitro-Diagnostika","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2024-10-15","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32023R0607",7116025,"ErwGr. 11","erwgr-11",null,"Erwägungsgründe","Die Verordnungen (EU) 2017\u002F745 und (EU) 2017\u002F746 sollten daher entsprechend geändert werden.","REG_2023_607 - Erwägungsgründe - ErwGr. 11\n\nDie Verordnungen (EU) 2017\u002F745 und (EU) 2017\u002F746 sollten daher entsprechend geändert werden.",{},[23,26,29],{"norm_key":24,"title":17,"slug":25},"ErwGr. 10","erwgr-10",{"norm_key":27,"title":17,"slug":28},"ErwGr. 9","erwgr-9",{"norm_key":30,"title":17,"slug":31},"ErwGr. 8","erwgr-8",[33,36,39],{"norm_key":34,"title":17,"slug":35},"ErwGr. 12","erwgr-12",{"norm_key":37,"title":17,"slug":38},"ErwGr. 13","erwgr-13",{"norm_key":40,"title":41,"slug":42},"Art. 1","Änderungen der Verordnung (EU) 2017\u002F745","art-1",[],true]